ND1.1

BIOLOGICAL2 trials

Sponsors

Vaxart

Conditions

Avian InfluenzaBird Flu

Phase 1

Safety Study of an Oral Vaccine to Prevent Avian Influenza

CompletedNCT01335347

VaxartAvian Influenza, Bird Flu

Start: 2011-04-30End: 2012-09-30Updated: 2013-01-03

Immunogenicity of ND1.1 by Delivery Directly to the Ileum

CompletedNCT01698060

VaxartAvian Influenza

Start: 2012-09-30End: 2013-11-30Updated: 2014-12-10

Related Papers

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans.

2013-01-2553 citations